Fundraising Fox
/Companies
Sign in

Blue Lake Biotechnology

Athens, US · Founded 2019 · Delaware corporation

Find your way into Blue Lake Biotechnology

Each arrow is one introduction. Sign up to fill in the first one.

538 people can intro you to Samuel

Ask Vincent Xiang to introduce you to Samuel Wu

You →Vincent · together at 7G BioVentures →Samuel

358 people can intro you to Marinka

Ask Jamie Chen to introduce you to Marinka Tellier

You →Jamie · together at NSF International →Marinka

Sign up to find every way you can get introduced to Blue Lake Biotechnology

  • Your email: who you already know at Blue Lake Biotechnology, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Blue Lake Biotechnology team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Blue Lake Biotechnology develops vaccines based on its PIV5 platform for infectious diseases, with programs including intranasal vaccine approaches. The company focuses on vaccine research and development for infectious disease targets.

BiotechHealthtech

Founders & leadership

Blue Lake Biotechnology was founded in 2019 by Biao He.

BH
Biao HeCEO
GT
Gary TitusCFO
HJ
Hong JinCSO
SWSamuel Wu
Samuel WuCBOHe has worked as a venture capital investor supporting biotech and medical device companies, consulted at McKinsey on corporate finance and commercialization strategy, and holds a PhD in science with clinical training.
HR
Hank RadziewiczCMO
MT
Marinka TellierChief Regulatory OfficerChief Regulatory Officer of Blue Lake Biotechnology, a vaccine company developing PIV5-based immunizations for infectious diseases. No prior professional background provided in the source material.
JA
Jixiang AnNamed on SEC filing
JM
Ji MaNamed on SEC filing
YL
Yuan LinNamed on SEC filing
FQ
Fred QuinnNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$18.8M disclosed across 2 of 3 rounds · 2019–2022

▶$10MraisedNov 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yuan LinDirector
  • Fred QuinnDirector
  • Ji MaDirector
  • Biao HeExecutive Officer, Director, Promoter
Offering amount
$10M
Amount sold
$10M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.8MraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Biao HeExecutive Officer, Director, Promoter
  • Jixiang AnDirector
  • Ji MaDirector
  • Yuan LinDirector
  • Fred QuinnDirector
Offering amount
$8.8M
Amount sold
$8.8M
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Silver LakeWaymo develops the Waymo Driver, an autonomous vehicle system that provides ride-hailing services across multiple metropolitan areas. The company operates commercial autonomous mobility services for consumers in major U.S. cities and expanding internationally.

Companies working in the same space as Blue Lake Biotechnology.

Frequently asked questions

What does Blue Lake Biotechnology do?
Blue Lake Biotechnology develops vaccines based on its PIV5 platform for infectious diseases, with programs including intranasal vaccine approaches. The company focuses on vaccine research and development for infectious disease targets.
Who founded Blue Lake Biotechnology?
Blue Lake Biotechnology was founded by Biao He in 2019.
How much funding has Blue Lake Biotechnology raised?
Blue Lake Biotechnology has disclosed $18.8M raised across 2 of its 3 known rounds.
Where is Blue Lake Biotechnology headquartered?
Blue Lake Biotechnology is headquartered in Athens, US.